0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Potential Safety Signals and Their Significance—Reply

G. Elliott Cook, PharmD, BCPS; Abbey Powers, PharmD
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.1297.
Text Size: A A A
Published online

Extract

In reply

We commend Dr Woo for highlighting additional processes used by the US Food and Drug Administration (FDA) to monitor and disseminate postmarketing drug safety information in accordance with the Food and Drug Administration Amendments Act. Also, we commend the commentaries of Wolf1 and Dal Pan and Temple.2 They highlight the importance of our study3 along with the importance of potential signals of serious risks identified through the Adverse Event Reporting System (AERS). We echo the concerns of Dal Pan and Temple,2 as there may be no easy solution for identified potential safety signals since evidence of a true signal is limited. Despite the limited evidence of a true signal, we firmly believe that health care professionals and the public should continue to monitor these reports from the FDA and choose alternative therapies when applicable if serious potential risks are present. Overall, we are in support of the comments by Wolf.1

Topics

safety

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

May 14, 2012
Emily Jane Woo, MD, MPH
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.833.
May 14, 2012
Gerald J. Dal Pan, MD, MHS
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.1035.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

26 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();